Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making

Brian T. Kadow; Jeffrey John Tomaszewski; Miki Haifler; Alexander Kutikov

doi:10.1007/978-3-030-36036-8_2

Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making

Brian T. Kadow
, Jeffrey John Tomaszewski
, Miki Haifler
, Alexander Kutikov

Fox Chase Cancer Center
Cooper University Health Care
Assaf Harofeh Medical Center

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

More frequent utilization of cross-sectional imaging has led to an increase in the incidental diagnosis and a subsequent rise in incidence of small renal masses. Historical biases and technical limitations have prevented renal mass biopsy (RMB) from becoming a universal part of routine patient evaluation at the time of diagnosis of a renal mass. Nevertheless, more recently, RMB is being more commonly utilized and offers real-world utility in risk-stratifying patients and appropriately matching them with an optimal treatment strategy.

Original language	English
Title of host publication	Renal Mass Biopsy
Subtitle of host publication	Indications, Risks, Technical Aspects and Future Trends
Publisher	Springer International Publishing
Pages	13-30
Number of pages	18
ISBN (Electronic)	9783030360368
ISBN (Print)	9783030360351
DOIs	https://doi.org/10.1007/978-3-030-36036-8_2
State	Published - Jan 1 2020

Keywords

Active surveillance
Cost-effectiveness
Partial nephrectomy
Radical nephrectomy
Renal cell carcinoma
Renal mass ablation
Renal mass biopsy
Small renal mass

Access to Document

10.1007/978-3-030-36036-8_2

Cite this

@inbook{d81b7015e07f4ecca98424db4c61e07d,

title = "Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making",

abstract = "More frequent utilization of cross-sectional imaging has led to an increase in the incidental diagnosis and a subsequent rise in incidence of small renal masses. Historical biases and technical limitations have prevented renal mass biopsy (RMB) from becoming a universal part of routine patient evaluation at the time of diagnosis of a renal mass. Nevertheless, more recently, RMB is being more commonly utilized and offers real-world utility in risk-stratifying patients and appropriately matching them with an optimal treatment strategy.",

keywords = "Active surveillance, Cost-effectiveness, Partial nephrectomy, Radical nephrectomy, Renal cell carcinoma, Renal mass ablation, Renal mass biopsy, Small renal mass",

author = "Kadow, \{Brian T.\} and Tomaszewski, \{Jeffrey John\} and Miki Haifler and Alexander Kutikov",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-36036-8\_2",

language = "English",

isbn = "9783030360351",

pages = "13--30",

booktitle = "Renal Mass Biopsy",

publisher = "Springer International Publishing",

address = "Switzerland",

}

TY - CHAP

T1 - Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making

AU - Kadow, Brian T.

AU - Tomaszewski, Jeffrey John

AU - Haifler, Miki

AU - Kutikov, Alexander

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2020.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - More frequent utilization of cross-sectional imaging has led to an increase in the incidental diagnosis and a subsequent rise in incidence of small renal masses. Historical biases and technical limitations have prevented renal mass biopsy (RMB) from becoming a universal part of routine patient evaluation at the time of diagnosis of a renal mass. Nevertheless, more recently, RMB is being more commonly utilized and offers real-world utility in risk-stratifying patients and appropriately matching them with an optimal treatment strategy.

AB - More frequent utilization of cross-sectional imaging has led to an increase in the incidental diagnosis and a subsequent rise in incidence of small renal masses. Historical biases and technical limitations have prevented renal mass biopsy (RMB) from becoming a universal part of routine patient evaluation at the time of diagnosis of a renal mass. Nevertheless, more recently, RMB is being more commonly utilized and offers real-world utility in risk-stratifying patients and appropriately matching them with an optimal treatment strategy.

KW - Active surveillance

KW - Cost-effectiveness

KW - Partial nephrectomy

KW - Radical nephrectomy

KW - Renal cell carcinoma

KW - Renal mass ablation

KW - Renal mass biopsy

KW - Small renal mass

UR - https://www.scopus.com/pages/publications/85149587274

U2 - 10.1007/978-3-030-36036-8_2

DO - 10.1007/978-3-030-36036-8_2

M3 - Chapter

AN - SCOPUS:85149587274

SN - 9783030360351

SP - 13

EP - 30

BT - Renal Mass Biopsy

PB - Springer International Publishing

ER -

Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this